Step forwards for spinal-cord repair.
Agoston
Helen
H
D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D020439:Growth Cones / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008954:Models, Biological; D009185:Myelin Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009416:Nerve Regeneration / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects / Q000254:growth & development*; D013119:Spinal Cord Injuries / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods / Q000639:trends; D054460:rho-Associated Kinases
D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D009185:Myelin Proteins; D003994:Bucladesine; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases